Show simple item record

dc.contributor.authorMunteanu, Cristian R.
dc.contributor.authorGutiérrez-Asorey, Pablo
dc.contributor.authorBlanes-Rodríguez, Manuel
dc.contributor.authorHidalgo-Delgado, Ismael
dc.contributor.authorBlanco Liverio, María de Jesús
dc.contributor.authorCastiñeiras Galdo, Brais
dc.contributor.authorPorto-Pazos, Ana B.
dc.contributor.authorGestal, Marcos
dc.contributor.authorArrasate Gil, Sonia
dc.contributor.authorGonzález Díaz, Humberto
dc.date.accessioned2021-11-24T12:58:21Z
dc.date.available2021-11-24T12:58:21Z
dc.date.issued2021-10-26
dc.identifier.citationInternational Journal of Molecular Sciences 22(21) : (2021) // Article ID 11519es_ES
dc.identifier.issn1422-0067,
dc.identifier.urihttp://hdl.handle.net/10810/54063
dc.description.abstractThe theoretical prediction of drug-decorated nanoparticles (DDNPs) has become a very important task in medical applications. For the current paper, Perturbation Theory Machine Learning (PTML) models were built to predict the probability of different pairs of drugs and nanoparticles creating DDNP complexes with anti-glioblastoma activity. PTML models use the perturbations of molecular descriptors of drugs and nanoparticles as inputs in experimental conditions. The raw dataset was obtained by mixing the nanoparticle experimental data with drug assays from the ChEMBL database. Ten types of machine learning methods have been tested. Only 41 features have been selected for 855,129 drug-nanoparticle complexes. The best model was obtained with the Bagging classifier, an ensemble meta-estimator based on 20 decision trees, with an area under the receiver operating characteristic curve (AUROC) of 0.96, and an accuracy of 87% (test subset). This model could be useful for the virtual screening of nanoparticle-drug complexes in glioblastoma. All the calculations can be reproduced with the datasets and python scripts, which are freely available as a GitHub repository from authors. View Full-Textes_ES
dc.description.sponsorshipThe APC was funded by IKERDATA, S.L. under grant 3/12/DP/2021/00102—Area 1: Development of innovative business projects, from Provincial Council of Vizcaya (BEAZ for the Creation of Innovative Business Innovative business ventures).es_ES
dc.language.isoenges_ES
dc.publisherMDPIes_ES
dc.rightsinfo:eu-repo/semantics/openAccesses_ES
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/
dc.subjectdecorated nanoparticleses_ES
dc.subjectdrug deliveryes_ES
dc.subjectanti-glioblastomaes_ES
dc.subjectbig dataes_ES
dc.subjectperturbation theoryes_ES
dc.subjectmachine learninges_ES
dc.subjectChEMBL databasees_ES
dc.titlePrediction of Anti-Glioblastoma Drug-Decorated Nanoparticle Delivery Systems Using Molecular Descriptors and Machine Learninges_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.date.updated2021-11-11T14:57:25Z
dc.rights.holder2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).es_ES
dc.relation.publisherversionhttps://www.mdpi.com/1422-0067/22/21/11519/htmes_ES
dc.identifier.doi10.3390/ijms222111519
dc.departamentoesQuímica Orgánica e Inorgánica
dc.departamentoeuKimika Organikoa eta Ez-Organikoa


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Except where otherwise noted, this item's license is described as 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).